Scolyer RA - Search Results

1

KEYNOTE-716: Phase III study of adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma.

Luke JJ, Ascierto PA, Carlino MS, Gershenwald JE, Grob JJ, Hauschild A, Kirkwood JM, Long GV, Mohr P, Robert C, Ross M, Scolyer RA, Yoon CH, Poklepovic A, Rutkowski P, Anderson JR, Ahsan S, Ibrahim N, M Eggermont AM. Luke JJ, et al. Among authors: scolyer ra. Future Oncol. 2020 Jan;16(3):4429-4438. doi: 10.2217/fon-2019-0666. Epub 2019 Dec 24. Future Oncol. 2020. PMID: 31870188 Free article.

2

Cutaneous melanoma.

Thompson JF, Scolyer RA, Kefford RF. Thompson JF, et al. Among authors: scolyer ra. Lancet. 2005 Feb 19-25;365(9460):687-701. doi: 10.1016/S0140-6736(05)17951-3. Lancet. 2005. PMID: 15721476 Review.

3

Intraoperative frozen-section evaluation can reduce accuracy of pathologic assessment of sentinel nodes in melanoma patients.

Scolyer RA, Thompson JF, McCarthy SW, Gershenwald JE, Ross MI, Cochran AJ. Scolyer RA, et al. J Am Coll Surg. 2005 Nov;201(5):821-3; author reply 823-4. doi: 10.1016/j.jamcollsurg.2005.07.017. J Am Coll Surg. 2005. PMID: 16256927 No abstract available.

4

Clinical relevance of melanoma micrometastases in sentinel nodes: too early to tell.

Scolyer RA, Murali R, Gershenwald JE, Cochran AJ, Thompson JF. Scolyer RA, et al. Ann Oncol. 2007 Apr;18(4):806-8. doi: 10.1093/annonc/mdm081. Ann Oncol. 2007. PMID: 17389530 Free article. No abstract available.

5

Surgery for melanoma metastases of the gastrointestinal tract: indications and results.

Sanki A, Scolyer RA, Thompson JF. Sanki A, et al. Among authors: scolyer ra. Eur J Surg Oncol. 2009 Mar;35(3):313-9. doi: 10.1016/j.ejso.2008.04.011. Epub 2008 Jun 30. Eur J Surg Oncol. 2009. PMID: 18590949

6

Sentinel lymph node biopsy for melanoma: aspects of pathologic assessment.

Murali R, Thompson JF, Scolyer RA. Murali R, et al. Among authors: scolyer ra. Future Oncol. 2008 Aug;4(4):535-51. doi: 10.2217/14796694.4.4.535. Future Oncol. 2008. PMID: 18684064 Review.

7

Cutaneous melanoma in the era of molecular profiling.

Thompson JF, Scolyer RA, Kefford RF. Thompson JF, et al. Among authors: scolyer ra. Lancet. 2009 Aug 1;374(9687):362-5. doi: 10.1016/S0140-6736(09)61397-0. Lancet. 2009. PMID: 19647595 Review. No abstract available.

8

Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma.

Long GV, Menzies AM, Nagrial AM, Haydu LE, Hamilton AL, Mann GJ, Hughes TM, Thompson JF, Scolyer RA, Kefford RF. Long GV, et al. Among authors: scolyer ra. J Clin Oncol. 2011 Apr 1;29(10):1239-46. doi: 10.1200/JCO.2010.32.4327. Epub 2011 Feb 22. J Clin Oncol. 2011. PMID: 21343559

9

Evolving concepts in melanoma classification and their relevance to multidisciplinary melanoma patient care.

Scolyer RA, Long GV, Thompson JF. Scolyer RA, et al. Mol Oncol. 2011 Apr;5(2):124-36. doi: 10.1016/j.molonc.2011.03.002. Epub 2011 Mar 21. Mol Oncol. 2011. PMID: 21482206 Free PMC article. Review.

10

Selective BRAF inhibitors induce marked T-cell infiltration into human metastatic melanoma.

Wilmott JS, Long GV, Howle JR, Haydu LE, Sharma RN, Thompson JF, Kefford RF, Hersey P, Scolyer RA. Wilmott JS, et al. Among authors: scolyer ra. Clin Cancer Res. 2012 Mar 1;18(5):1386-94. doi: 10.1158/1078-0432.CCR-11-2479. Epub 2011 Dec 12. Clin Cancer Res. 2012. PMID: 22156613

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

820 results

Search Page